Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIBERAL study
2023-507823-52-00Phase 3Completed
- Sponsor
- Leiden University Medical Center
- Start
- Feb 2024
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of sodium zirconium cyclosilicate in chronic kidney disease (CKD) (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Change in serum potassium at 6 weeks (intention-to-treat). Started Feb 2024; status: completed.
02
Drugs
sodium zirconium cyclosilicate
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2023-507823-52-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-507823-52-00.